Skip to main content
International Journal of Environmental Research and Public Health logoLink to International Journal of Environmental Research and Public Health
. 2021 Jan 28;18(3):1131. doi: 10.3390/ijerph18031131

Sub-Clinical Effects of Outdoor Smoke in Affected Communities

Thomas O’Dwyer 1,, Michael J Abramson 1,*,, Lahn Straney 1, Farhad Salimi 1, Fay Johnston 2, Amanda J Wheeler 2,3, David O’Keeffe 1, Anjali Haikerwal 1, Fabienne Reisen 4, Ingrid Hopper 1, Martine Dennekamp 1,5,
Editor: Paul Tchounwou
PMCID: PMC7908479  PMID: 33525316

Abstract

Many Australians are intermittently exposed to landscape fire smoke from wildfires or planned (prescribed) burns. This study aimed to investigate effects of outdoor smoke from planned burns, wildfires and a coal mine fire by assessing biomarkers of inflammation in an exposed and predominantly older population. Participants were recruited from three communities in south-eastern Australia. Concentrations of fine particulate matter (PM2.5) were continuously measured within these communities, with participants performing a range of health measures during and without a smoke event. Changes in biomarkers were examined in response to PM2.5 concentrations from outdoor smoke. Increased levels of FeNO (fractional exhaled nitric oxide) (β = 0.500 [95%CI 0.192 to 0.808] p < 0.001) at a 4 h lag were associated with a 10 µg/m3 increase in PM2.5 levels from outdoor smoke, with effects also shown for wildfire smoke at 4, 12, 24 and 48-h lag periods and coal mine fire smoke at a 4 h lag. Total white cell (β = −0.088 [−0.171 to −0.006] p = 0.036) and neutrophil counts (β = −0.077 [−0.144 to −0.010] p = 0.024) declined in response to a 10 µg/m3 increase in PM2.5. However, exposure to outdoor smoke resulting from wildfires, planned burns and a coal mine fire was not found to affect other blood biomarkers.

Keywords: smoke, PM2.5, landscape fire, bushfire, biomarkers, FeNO, neutrophils, white cell count

1. Introduction

With climate change, wildfires in Australia are forecast to increase in frequency and severity [1,2,3]. Wildfires present physical risks to individuals and communities from both direct exposure to intense heat and flames, but also from widespread exposure to smoke [4]. Planned (prescribed) burns are conducted to reduce fire fuel loads in bushland and areas surrounding communities [5]. These are designed to reduce the risk of catastrophic wildfires [6,7]. Both wildfires and planned burns are a common occurrence in Australia, and exposure to smoke from wildfires or planned burns is inevitable for the majority of Australians [8].

Wild fire and planned burn smoke contains a variety of inorganic and organic compounds, as well as airborne particulates [9]. Particulate matter with a median aerodynamic diameter smaller than 2.5 micrometres (PM2.5) is a significant component of the smoke [10]. The small size of these fine particles allows them to penetrate deeply into the lungs [11]. These fine particulates have been linked with chronic health conditions, such as asthma, chronic obstructive pulmonary disease (COPD), ischaemic heart disease (IHD) and lower respiratory infections (LRI) [12].

While the acute effects of urban background PM2.5 are well documented for premature mortality, hospital admissions, emergency presentations and ambulance call-outs [12], the acute effects of PM2.5 on biomarkers of systemic and airway inflammation are less well understood, particularly in the context of smoke from wild fires. Exposure to smoke from wild fire smoke has been associated with an increased risk of out of hospital cardiac arrests and IHD [13]. Most studies involving the health effects of wild fires focus on discrete outcomes and events such as mortality and hospital episodes [14,15,16]. However, there has been limited evidence of the acute effects of exposure to outdoor smoke on populations. This study investigated the effect of short-term exposures to wild fire, planned burn, and coal mine fire smoke on markers of inflammation.

2. Materials and Methods

We performed a short-term panel study of rural Victorian residents during the prescribed burns season and winter period over four consecutive years (Table 1). The detailed methodology has been published previously [17]. We present here a brief summary of the methods.

Table 1.

Number of assessments conducted per year and exposure type. Note that no clean air assessments were conducted in 2016. Assessments were carried out on those participants who were tested in Warburton in 2015 when there was no smoke.

Location and Year Number of Assessments Type of Smoke Number of Assessments Type of Smoke
Warburton 2013 14 Planned burn 10 No smoke
Warburton 2014 44 Wild fire 39 No smoke
Traralgon 2014 42 Coal Mine Fire 29 No smoke
Maffra 2014 21 No smoke 14 No smoke
Warburton 2015 7 Planned burn 78 No smoke
Warburton 2016 55 Planned burn
Total 183 170

2.1. Participants

Communities likely to be impacted by smoke from planned burns were identified in conjunction with the Victorian Department of Environment, Land, Water and Planning (DELWP), the agency responsible for conducting planned burns. Three towns were identified as suitable study locations in Victoria: Warburton, Traralgon and Maffra/Heyfield [17] (Figure 1). Residents aged 18 and over were recruited through random digit dialing to identify interested individuals, with follow-up telephone calls, community advertising and letter box drops of study information. The aim was for half the sample to be over 65 years of age, as older age is a risk factor for adverse health outcomes from air pollution. There were no exclusion criteria based on current health or medical conditions.

Figure 1.

Figure 1

Study locations: Victoria, Australia.

2.2. Study Period

The study was conducted from Autumn 2013 to Autumn 2016.

2.3. Health Assessments

Participants attended two appointments for clinical testing, one during a period with no known source of outdoor smoke (the clean air assessment) and one during a smoke event. Clinical tests included:

  • Blood tests, for markers of inflammation and coagulation, specifically high sensitivity C-reactive protein (CRP), fibrinogen, and a full blood examination (including hemoglobin, total and differential white cell and platelet counts) [17].

  • Airway inflammation test, measuring fractional exhaled nitric oxide (FeNO) using a NiOx unit (Aerocrine AB, Solna, Sweden) [18].

2.4. Exposure Assessment

At a central location in each of the three study areas, an E-sampler aerosol monitor (Met One Instruments Inc., Grants Pass, OR, USA) was set up. The E-sampler measured continuous PM2.5 concentrations by light scattering, and collected gravimetric measurements on filters, which were used to determine a calibration factor.

2.5. Statistical Analysis

Comparisons between men and women were made with Pearson χ2 or Fisher’s exact tests. Generalized estimating equations (GEE) were fitted to assess the relationships between the biomarkers and PM2.5 [19,20]. The GEE calculated the average change in clinical measures for each 10 μg/m3 increase in PM2.5 with 95% confidence intervals (this was a realistic increase). Data were analyzed using Stata statistical software (Version 12.1, StataCorp, College Station, TX, USA).

Markers of lung and systemic inflammation (FeNO, total white cell (WCC), neutrophil, basophil counts, and high sensitivity C-reactive protein (CRP)) were the continuous outcomes (dependent variables). The exposure variables were hourly averaged PM2.5 concentrations. Analyses were performed for the following lag periods: 4 h (PM2.5 concentration in the 4 h prior to the test), 8 h, 12 h, 24 h and 48 h.

The parameter estimates from the GEE models may be interpreted as proportional changes in the levels of individual biomarkers. We calculated the changes in biomarker levels associated with exposure per 10 µg/m3 PM2.5 from outdoor smoke.

All analyses controlled for known confounders of temperature and humidity. Secondary analyses also controlled for individual smoking status, age and history of asthma. All analyses were conducted using Stata (version 14.1; StataCorp, College Station, TX, USA). p-values < 0.05 were considered statistically significant [21].

2.6. Ethics Approval

This study was approved by the Monash University Human Research Ethics Committee CF12/3097-2012001570 and the Human Research Ethics Committee of the University of Tasmania, reference number H0013022. All participants provided written, informed consent.

3. Results

There was a total of 207 participants enrolled in the full study with a subset of 183 who completed repeat measurements included in these analyses (Supplementary File S1). The participants’ mean age (SD, min and max) was 63.5 (12.2, 26 and 92) years and 60% were female (Table 2). Just under half (46%) of the participants were aged over 65 years. A similar proportion had ever smoked tobacco for at least one year. Inhabitants had lived in the study region for a median of 22 (IQR 10 to 38 years) and the majority (69%) were from Warburton. Common co-morbidities included asthma, COPD, ischemic heart disease, heart failure and diabetes. The men were significantly older than the women, less likely to be current smokers and more likely to have heart failure or other heart conditions.

Table 2.

Demographics and clinical characteristics of study participants.

Characteristic Women Total
(n = 110)
Proportions Men Total
(n = 73)
Proportions p-Value
Age > 65 years 40 36.0% 44 60.3% 0.001
Current regular smoker 15 13.6% 3 4.1% 0.034
Smoked at all last month 33 30.0% 20 27.4% 0.75
Ever smoked 41 37.2% 32 43.8% 0.72
Asthma diagnosed 17 15.5% 12 16.4% 0.86
Asthma attack in the last 12 months 6 5.5% 0 0% 0.028 *
Asthma medication 10 9.1% 8 11.0% 0.97
COPD 4 3.6% 4 5.6% 0.80
Other respiratory condition 6 5.5% 5 6.8% 0.94
Hypertension 41 37.3% 28 38.4% 0.88
Angina 4 3.6% 7 9.6% 0.18
High Cholesterol 31 28.2% 21 28.8% 0.93
Myocardial infarction or coronary event 5 4.5% 9.6% 0.23 *
Heart Failure 1 0.9% 5 6.8% 0.039 *
Arrhythmia 14 12.7% 10 13.7% 0.85
Stroke or TIA 2 1.8% 5 6.8% 0.12 *
Other heart condition 3 2.7% 8 11.0% 0.028 *
Diabetes 14 12.7% 9 12.3% 0.94
Self-reported cold or flu symptoms 18 16.5% 10 13.7% 0.61
Immune modulators 3 2.7% 0 0.0% -
Non-Steroidal anti-inflammatories 2 1.8% 1 1.4% -
Anti-platelet medication 8 7.2% 8 10.9% -
Asthma Inhalers/preventers 10 9.1% 8 10.9% -
Antihistamines 2 1.8% 0 0.0% -

* Fisher’s exact test.

There was significant variation in the exposure to PM2.5 from the different smoke sources. Planned burns and wildfire smoke were only recorded in Warburton (Figure 2 and Figure 3) due to limited burning seasons across the 4-year study period. No smoke from any source was detected in Maffra/Heyfield during the study period, as scheduled planned burns did not proceed during this time due to local weather conditions. In 2014, there was a coal mine fire near Traralgon, and the air quality in Traralgon was impacted by the smoke from these fires during our study (Figure 4).

Figure 2.

Figure 2

Average 24 h concentrations of PM2.5 (µg/m3) measured in Warburton between 1 March and 30 April 2016. Health assessments were conducted on 1 April 2016 and 19–21 April 2016. Note that planned burns were conducted near Warburton during the study.

Figure 3.

Figure 3

Boxplots showing median, quartiles and extreme concentrations of PM2.5 (µg/m3) as measured on the day’s health assessments were conducted in Warburton in 2014. Note that wildfires only occurred near Warburton during this study period.

Figure 4.

Figure 4

Boxplots showing median, quartiles and extreme concentrations of PM2.5 (µg/m3) as measured on the day’s health assessments were conducted in Traralgon. Note that the coal mine fire only impacted Traralgon during the study.

The fractional exhaled nitric oxide (FeNO) showed positive relationships with increasing concentrations of PM2.5 from outdoor smoke (resulting from wild fires, planned burns or a coal mine fire) for the preceding 4-, 12-, 24- or 48-h (Table 3). Total white cell (WCC) counts showed significant declines at 24-h lag period and neutrophils at 24- and 48-h lag periods associated with PM2.5 exposures from outdoor smoke events (Table 4). No significant changes associated with any exposure were seen for eosinophils, monocytes and platelets, fibrinogen or C-reactive protein (data not shown). The stratified analysis for the different sources of the smoke (coal mine fire, planned burn and forest fire smoke) showed positive associations between FeNO and exposure to coal mine fire smoke for the 4-h lag period (Table 3).

Table 3.

Changes in fractional exhaled nitric oxide (FeNO) (ppb) Regression coefficients (β) and 95% confidence intervals per 10 µg/m3 PM2.5 adjusted for temperature, humidity, smoking status, asthma diagnosis and age.

Exposure Type Lag Period (h) β 95% CI p
All 4 0.500 (0.192 to 0.808) <0.001
Planned Burn Smoke 4 0.335 (−0.012 to 0.681) 0.058
Wildfire Smoke 4 0.644 (0.447 to 0.842) <0.001
Coal Mine Fire 4 1.533 (0.461 to 2.605) 0.005
All 12 0.308 (0.028 to 0.588) 0.031
Planned Burns Smoke 12 0.269 (−0.014 to 0.553) 0.063
Wildfire Smoke 12 1.027 (0.816 to 1.239) <0.001
Coal Mine Fire Smoke 12 0.196 (−1.467 to 1.859) 0.817
All 24 0.381 (−0.036 to 0.798) 0.073
Planned Burns Smoke 24 0.497 (−0.050 to 1.044) 0.075
Wildfire Smoke 24 1.073 (0.846 to 1.299) <0.001
Coal Mine Fire Smoke 24 0.538 (−1.431 to 2.506) 0.593
All 48 0.344 (−0.154 to 0.842) 0.176
Planned Burns Smoke 48 0.761 (−0.165 to 1.686) 0.107
Wildfire Smoke 48 0.789 (0.539 to 1.040) <0.001
Coal Mine Fire Smoke 48 −0.148 (−2.150 to 1.854) 0.885

Table 4.

Changes in total white cell count (WCC) and neutrophil counts Regression coefficients (β) and 95% confidence intervals per 10 µg/m3 PM2.5 adjusted for temperature, humidity, smoking status, asthma diagnosis and age.

Exposure Type Outcome Exposure Period (h) β 95% CI p
All WCC 24 −0.088 (−0.171 to −0.006) 0.036
Planned Burns WCC 24 −0.069 (−0.178 to 0.041) 0.218
Wildfire Smoke WCC 24 −0.108 (−0.235 to 0.018) 0.094
Coal Mine Fire WCC 24 −0.203 (−0.605 to 0.200) 0.324
All WCC 48 −0.092 (−0.192 to 0.007) 0.070
All Neutrophils 24 −0.077 (−0.144 to −0.010) 0.024
Planned Burns Neutrophils 24 −0.065 (−0.156 to 0.026) 0.162
Wildfire Smoke Neutrophils 24 −0.083 (−0.185 to 0.019) 0.112
Coal Mine Fire Neutrophils 24 −0.147 (−0.469 to 0.175) 0.370
All Neutrophils 48 −0.081 (−0.162 to −0.001) 0.048

4. Discussion

This panel study showed that outdoor smoke (smoke from planned burns, wildfires and a coal mine fire) had an impact on biomarkers, including total white cell and neutrophil counts, as well as increasing the fractional exhaled nitric oxide consistent with systemic and airway inflammation.

The results for FeNO were consistent with previous studies, indicating that PM2.5 was associated with eosinophilic airway inflammation [22,23,24,25]. Our results confirmed these findings, showing positive associations between PM2.5 from outdoor smoke and FeNO.

There was less consistency between the results for the blood markers in our study and other studies. Previous studies found increases in CRP [26] and fibrinogen associated with PM2.5 from urban background air pollution, including traffic and woodsmoke [27,28,29,30,31]. It has also been shown in response to transient exposure to PM2.5 from biomass smoke exposure [32,33] in Finland and North America. This may indicate different components of these particulate fractions from alternative sources may produce different biological responses, differences in exposure profiles, or it may indicate that smoke from wildfires produces different changes in biomarkers depending on the type of vegetation that burns. Equally, different responses of biomarkers to PM2.5 exposure could be related to duration of exposure or lack of statistical power.

Mean levels of urban background PM2.5 observed by Huttenen et al. [32] were lower (8.7 µg/m3) than in our study, however blood samples were taken bi-weekly, which may have increased sensitivity to changes in biomarkers. Adetona et al. observed PM2.5 TWA levels of 338 µg/m3 and 240 µg/m3 in their exposed sample of firefighters, with samples being taken immediately following shifts [33]. There were cross-shift increases in IL8, CRP, serum amyloid A and segmented neutrophils in peripheral blood.

As Huttunen et al. [32] conducted their study in patients with heart disease, the effect of biomass smoke may have been more pronounced than in our sample. However, our panel was composed mainly of elderly individuals, with a high prevalence of heart disease. Equally, Adetona et al. [33] may have detected an increase in CRP due to the fire fighters’ close proximity to the smoke source and the very high levels of exposure. However, the strength of this interaction could also have been mitigated by a healthy worker effect. Finally, increased CRP may be a sign of other inflammatory responses not related to smoke, perhaps masking any true effects.

Previously, total WCC has been found to be associated with urban background PM10 [34]. This may be due to different cellular responses to larger particulate fractions, or from differences in particle composition. Ghio et al. [35] demonstrated increased levels of neutrophils in bronchial and bronchoalveolar lavage sampled in participants exposed to PM2.5 from wood smoke. Decreases in neutrophils and total WCC count may indicate cells moving out of the peripheral blood and into the lungs in response to inflammation. This could be investigated further through bronchoalveolar lavage or analysis of exhaled breath for neutrophil markers.

These results highlight the potential sub-clinical changes resulting from outdoor smoke exposures. Previous work relating to landscape fires has mainly measured clinical outcomes such as cardiac arrests and asthma attacks. Our findings suggest that individuals with asthma should try to reduce their exposure to smoke during wildfires or planned burns [36]. Importantly, this study also provides a crucial insight into the sub-clinical changes which may occur in the lead up to an individual suffering an overt adverse health effect. Further research is needed to determine if this finding is repeated under similar conditions.

Strengths and Limitations

This study used the paired data from individuals to provide an objective measurement of the impact of PM2.5 on selected biomarkers. By measuring biomarkers, we were able to demonstrate objective changes in inflammation and clinically relevant endpoints. As these measurements were sub-clinical, our study provided an important indication of subtle health changes during smoke-related PM2.5 exposure.

The main limitation of this study was the difficulty in obtaining a consistent exposure to smoke due to meteorological variation. Changes in local weather conditions often resulted in planned burns not occurring, or the smoke not impacting the town. This may have reduced the chance of finding a potential association between smoke from planned burns and changes in biomarkers. On the days when planned burns were occurring nearby, there were frequently negligible amounts of smoke present in the study area. This was likely due to burn protocols designed to reduce the impact of smoke on communities as much as is practicable. Equally, the changes only demonstrated correlation and not necessarily causation. As the panel study relied on repeated measures of returning participants, there may be a healthy volunteer bias. Another limitation was the time between paired measurements. Due to changes in the planned burn schedule, there were gaps between the initial ‘clean’ measurement and the “smoke” measurement of several weeks or months. Although we have demonstrated similar responses to different sources of smoke, we accept that the findings should be generalized to other settings with caution.

However, this study has identified health impacts of planned burn smoke on FeNO and white cell counts. Further research should focus on the potential impact of smoke-related PM2.5 on vulnerable populations, particularly individuals with pre-existing cardiovascular and respiratory conditions. In order to determine if the reduction in WCC and neutrophils numbers is due to these cells migrating from the peripheral blood to the lungs, future studies are recommended of these effects on more highly exposed populations, such as firefighters working on wild fires or planned burns.

5. Conclusions

Outdoor smoke from wildfires, planned burns and a coal mine fire were associated with increased levels of FeNO, but decreased neutrophils and total WCC in peripheral blood. This suggests that PM2.5 may cause increased airway inflammation. This may have significant clinical implications for individuals with pre-existing respiratory conditions or compromised immune systems. However, there was no evidence of systemic inflammation.

Acknowledgments

I.H. is supported by the National Health and Medical Research Council of Australia.

Supplementary Materials

The following are available online at https://www.mdpi.com/1660-4601/18/3/1131/s1, File S1: Health effects of smoke from planned burning—Baseline Questionnaires.

Author Contributions

Conceptualization, M.J.A., F.J., F.R. and M.D.; methodology, T.O., A.J.W., D.O., F.R. and M.D.; formal analysis, T.O., L.S., F.S. and M.J.A.; investigation, T.O., D.O. and A.H.; resources, F.R.; data curation, L.S.; writing—original draft preparation, T.O.; writing—review and editing, all authors; visualization, T.O., M.J.A. and F.R.; supervision, M.J.A., M.D. and I.H.; project administration, F.J. and M.D.; funding acquisition, M.J.A., F.J., F.R. and M.D.; validation, A.J.W. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Victorian Department of Environment, Land, Water and Planning (DELWP).

Institutional Review Board Statement

This study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Human Research Ethics Committee of Monash University (CF12/3097-2012001570, 11 December 2012) and the Human Research Ethics Committee of the University of Tasmania (H0013022, 7 February 2013).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on reasonable request from the corresponding author. The data are not publicly available due to ethical requirements.

Conflicts of Interest

M.J.A. holds investigator-initiated grants from Pfizer and Boehringer-Ingelheim for unrelated research. He has undertaken an unrelated consultancy for, and received assistance with, conference attendance from Sanofi. He has received a speaker’s fee from GSK. The other authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Footnotes

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Huang Y., Wu S., Kaplan J.O. Sensitivity of global wildfire occurrences to various factors in the context of global change. Atmos. Environ. 2015;121:86–92. doi: 10.1016/j.atmosenv.2015.06.002. [DOI] [Google Scholar]
  • 2.Sharples J.J., Cary G.J., Fox-Hughes P., Mooney S., Evans J.P., Fletcher M.-S., Fromm M., Grierson P.F., McRae R., Baker P. Natural hazards in Australia: Extreme bushfire. Clim. Chang. 2016;139:85–99. doi: 10.1007/s10584-016-1811-1. [DOI] [Google Scholar]
  • 3.Keywood M., Kanakidou M., Stohl A., Dentener F., Grassi G., Meyer C.P., Torseth K., Edwards D., Thompson A.M., Lohmann U., et al. Fire in the Air: Biomass Burning Impacts in a Changing Climate. Crit. Rev. Environ. Sci. Technol. 2011;43:40–83. doi: 10.1080/10643389.2011.604248. [DOI] [Google Scholar]
  • 4.Keywood M., Cope M., Meyer C.M., Iinuma Y., Emmerson K. When smoke comes to town: The impact of biomass burning smoke on air quality. Atmos. Environ. 2015;121:13–21. doi: 10.1016/j.atmosenv.2015.03.050. [DOI] [Google Scholar]
  • 5.Penman T.D., Christie F.J., Andersen A.N., Bradstock R.A., Cary G.J., Henderson M.K., Price O., Tran C., Wardle G.M., Williams R.J., et al. Prescribed burning: How can it work to conserve the things we value? Int. J. Wildland Fire. 2011;20:721–733. doi: 10.1071/WF09131. [DOI] [Google Scholar]
  • 6.Bradstock R.A., Cary G., Davies I., Lindenmayer D., Price O., Williams R. Wildfires, fuel treatment and risk mitigation in Australian eucalypt forests: Insights from landscape-scale simulation. J. Environ. Manag. 2012;105:66–75. doi: 10.1016/j.jenvman.2012.03.050. [DOI] [PubMed] [Google Scholar]
  • 7.Boer M.M., Sadler R.J., Wittkuhn R.S., McCaw L., Grierson P.F. Long-term impacts of prescribed burning on regional extent and incidence of wildfires—Evidence from 50 years of active fire management in SW Australian forests. For. Ecol. Manag. 2009;259:132–142. doi: 10.1016/j.foreco.2009.10.005. [DOI] [Google Scholar]
  • 8.Johnston F.H. Bushfires and human health in a changing environment. Aust. Fam. Physician. 2009;38:720–724. [PubMed] [Google Scholar]
  • 9.Alves C., Gonçalves C., Evtyugina M., Pio C., Mirante F., Puxbaum H. Particulate organic compounds emitted from experimental wildland fires in a Mediterranean ecosystem. Atmos. Environ. 2010;44:2750–2759. doi: 10.1016/j.atmosenv.2010.04.029. [DOI] [Google Scholar]
  • 10.Garcia-Hurtado E., Pey J., Borrás E., Sánchez P., Vera T., Carratalá A., Alastuey A., Querol X., Vallejo V.R. Atmospheric PM and volatile organic compounds released from Mediterranean shrubland wildfires. Atmos. Environ. 2014;89:85–92. doi: 10.1016/j.atmosenv.2014.02.016. [DOI] [Google Scholar]
  • 11.Feng S.-L., Gao D., Liao F., Zhou F., Wang X. The health effects of ambient PM2.5 and potential mechanisms. Ecotoxicol. Environ. Saf. 2016;128:67–74. doi: 10.1016/j.ecoenv.2016.01.030. [DOI] [PubMed] [Google Scholar]
  • 12.Cohen A.J., Brauer M., Burnett R., Anderson H.R., Frostad J., Estep K., Balakrishnan K., Brunekreef B., Dandona L., Dandona R., et al. Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: An analysis of data from the Global Burden of Diseases Study 2015. Lancet. 2017;389:1907–1918. doi: 10.1016/S0140-6736(17)30505-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Haikerwal A., Akram M., Del Monaco A., Smith K., Sim M.R., Meyer M., Tonkin A.M., Abramson M.J., Dennekamp M. Impact of Fine Particulate Matter (PM 2.5) Exposure During Wildfires on Cardiovascular Health Outcomes. J. Am. Hear. Assoc. 2015;4:e001653. doi: 10.1161/JAHA.114.001653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kollanus V., Tiittanen P., Niemi J.V., Lanki T. Effects of long-range transported air pollution from vegetation fires on daily mortality and hospital admissions in the Helsinki metropolitan area, Finland. Environ. Res. 2016;151:351–358. doi: 10.1016/j.envres.2016.08.003. [DOI] [PubMed] [Google Scholar]
  • 15.Sigsgaard T., Forsberg B., Annesi-Maesano I., Blomberg A., Bølling A., Boman C., Bønløkke J., Brauer M., Bruce N., Héroux M.-E., et al. Health impacts of anthropogenic biomass burning in the developed world. Eur. Respir. J. 2015;46:1577–1588. doi: 10.1183/13993003.01865-2014. [DOI] [PubMed] [Google Scholar]
  • 16.Kollanus V., Prank M., Gens A., Soares J., Vira J., Kukkonen J., Sofiev M., Salonen R.O., Lanki T. Mortality due to Vegetation Fire—Originated PM 2.5 Exposure in Europe—Assessment for the Years 2005 and 2008. Environ. Health Perspect. 2017;125:30–37. doi: 10.1289/EHP194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.O’Keeffe D., Dennekamp M., Straney L.D., Mazhar M., O’Dwyer T., Haikerwal A., Reisen F., Abramson M.J., Johnston F.H. Health effects of smoke from planned burns: A study protocol. BMC Public Health. 2016;16:186. doi: 10.1186/s12889-016-2862-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.American Thoracic Society/European Respiratory Society recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. [(accessed on 27 January 2021)];Am. J. Respir. Crit. Care Med. 2005 171:912–930. doi: 10.1164/rccm.200406-710ST. Available online: https://www.atsjournals.org/doi/pdf/10.1164/rccm.200406-710ST. [DOI] [PubMed] [Google Scholar]
  • 19.Stebbings J.H. Panel studies of acute health effects of air pollution: II. A methodologic study of linear regression analysis of asthma panel data. Environ. Res. 1978;17:10–32. doi: 10.1016/0013-9351(78)90057-9. [DOI] [PubMed] [Google Scholar]
  • 20.Hardin J.W., Hilbe J.M. Generalized Estimating Equations. Chapman & Hall/CRC; Boca Raton, FL, USA: 2013. [Google Scholar]
  • 21.StataCorp . Stata Statistical Software: Release 14. StataCorp LP; College Station, TX, USA: 2015. [Google Scholar]
  • 22.Allen R.W., Mar T., Koenig J., Liu L.-J.S., Gould T., Simpson C., Larson T. Changes in Lung Function and Airway Inflammation Among Asthmatic Children Residing in a Woodsmoke-Impacted Urban Area. Inhal. Toxicol. 2008;20:423–433. doi: 10.1080/08958370801903826. [DOI] [PubMed] [Google Scholar]
  • 23.Barregard L., Sallsten G., Andersson L., Almstrand A.-C., Gustafson P., Olin A.-C. Experimental exposure to wood smoke: Effects on airway inflammation and oxidative stress. Occup. Environ. Med. 2008;65:319–324. doi: 10.1136/oem.2006.032458. [DOI] [PubMed] [Google Scholar]
  • 24.Stockfelt L., Sallsten G., Olin A.-C., Almerud P., Samuelsson L., Johannesson S., Molnar P., Strandberg B., Almstrand A.-C., Bergemalm-Rynell K., et al. Effects on airways of short-term exposure to two kinds of wood smoke in a chamber study of healthy humans. Inhal. Toxicol. 2011;24:47–59. doi: 10.3109/08958378.2011.633281. [DOI] [PubMed] [Google Scholar]
  • 25.Abramson M.J., Wigmann C., Altug H., Schikowski T. Ambient air pollution is associated with airway inflammation in older women: A nested cross-sectional analysis. BMJ Open Respir. Res. 2020;7:e000549. doi: 10.1136/bmjresp-2019-000549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Viehmann A., Hertel S., Fuks K., Eisele L., Moebus S., Möhlenkamp S., Nonnemacher M., Jakobs H., Erbel R., Jöckel K.-H., et al. Long-term residential exposure to urban air pollution, and repeated measures of systemic blood markers of inflammation and coagulation. Occup. Environ. Med. 2015;72:656–663. doi: 10.1136/oemed-2014-102800. [DOI] [PubMed] [Google Scholar]
  • 27.Bind M.-A., Baccarelli A., Zanobetti A., Tarantini L., Suh H., Vokonas P., Schwartz J. Air pollution and markers of coagulation, inflammation, and endothelial function: Associations and epigene-environment interactions in an elderly cohort. Epidemiology. 2012;23:332–340. doi: 10.1097/EDE.0b013e31824523f0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Green R., Broadwin R., Malig B., Basu R., Gold E.B., Qi L., Sternfeld B., Bromberger J.T., Greendale G.A., Kravitz H.M., et al. Long-and Short-Term Exposure to Air Pollution and Inflammatory/Hemostatic Markers in Midlife Women. Epidemiology. 2015;27:211–220. doi: 10.1097/EDE.0000000000000421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kajbafzadeh M., Brauer M., Karlen B., Carlsten C., Van Eeden S., Allen R.W. The impacts of traffic-related and woodsmoke particulate matter on measures of cardiovascular health: A HEPA filter intervention study. Occup. Environ. Med. 2015;72:394–400. doi: 10.1136/oemed-2014-102696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Sarnat J.A., Golan R., Greenwald R., Raysoni A.U., Kewada P., Winquist A., Sarnat S.E., Flanders W.D., Mirabelli M.C., Zora J.E., et al. Exposure to traffic pollution, acute inflammation and autonomic response in a panel of car commuters. Environ. Res. 2014;133:66–76. doi: 10.1016/j.envres.2014.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Croft D.P., Cameron S.J., Morrell C.N., Lowenstein C.J., Ling F., Zareba W., Hopke P.K., Utell M.J., Thurston S.W., Thevenet-Morrison K., et al. Associations between ambient wood smoke and other particulate pollutants and biomarkers of systemic inflammation, coagulation and thrombosis in cardiac patients. Environ. Res. 2017;154:352–361. doi: 10.1016/j.envres.2017.01.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Huttunen K., Siponen T., Salonen I., Yli-Tuomi T., Aurela M., Dufva H., Hillamo R., Linkola E., Pekkanen J., Pennanen A., et al. Low-level exposure to ambient particulate matter is associated with systemic inflammation in ischemic heart disease patients. Environ. Res. 2012;116:44–51. doi: 10.1016/j.envres.2012.04.004. [DOI] [PubMed] [Google Scholar]
  • 33.Adetona A.M., Adetona O., Gogal R.M., Diaz-Sanchez D., Rathbun S.L., Naeher L.P. Impact of Work Task-Related Acute Occupational Smoke Exposures on Select Proinflammatory Immune Parameters in Wildland Firefighters. J. Occup. Environ. Med. 2017;59:679–690. doi: 10.1097/JOM.0000000000001053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Schwartz J. Air Pollution and Blood Markers of Cardiovascular Risk. Environ. Health Perspect. 2001;109:405. doi: 10.2307/3434788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Ghio A.J., Soukup J.M., Case M., Dailey L.A., Richards J., Berntsen J., Devlin R.B., Stone S., Rappold A. Exposure to wood smoke particles produces inflammation in healthy volunteers. Occup. Environ. Med. 2011;69:170–175. doi: 10.1136/oem.2011.065276. [DOI] [PubMed] [Google Scholar]
  • 36.Carlsten C., Salvi S., Wong G.W., Chung K.F. Personal strategies to minimise effects of air pollution on respiratory health: Advice for providers, patients and the public. Eur. Respir. J. 2020;55:1902056. doi: 10.1183/13993003.02056-2019. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Availability Statement

The data presented in this study are available on reasonable request from the corresponding author. The data are not publicly available due to ethical requirements.


Articles from International Journal of Environmental Research and Public Health are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES